Isocitrate dehydrogenase (IDH) mutant gliomas show accelerated progression from an indolent course to a fulminant malignant phase after first recurrence, specialists have found.
Isocitrate dehydrogenase (IDH) mutant gliomas show accelerated progression from an indolent course to a fulminant malignant phase after first recurrence, specialists have found.